{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T22:32:18Z","timestamp":1773527538524,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003663","name":"Korea Small and Medium Business Administration","doi-asserted-by":"crossref","award":["C0333276"],"award-info":[{"award-number":["C0333276"]}],"id":[{"id":"10.13039\/501100003663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00253-016-7717-z","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T14:45:01Z","timestamp":1469717101000},"page":"10521-10529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor"],"prefix":"10.1007","volume":"100","author":[{"given":"Ji-Hun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Won","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Geun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonghwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeheun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Ryul","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hyeon","family":"Seok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Duk","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Chul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Pil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Sik","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"key":"7717_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213\u2013221","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"7717_CR2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.copbio.2004.08.002","volume":"15","author":"DC Andersen","year":"2004","unstructured":"Andersen DC, Reilly DE (2004) Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol 15:456\u2013462","journal-title":"Curr Opin Biotechnol"},{"key":"7717_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10555-005-6193-1","volume":"24","author":"M Arbabi-Ghahroudi","year":"2005","unstructured":"Arbabi-Ghahroudi M, Tanha J, MacKenzie R (2005) Prokaryotic expression of antibodies. Cancer Metastasis Rev 24:501\u2013519","journal-title":"Cancer Metastasis Rev"},{"key":"7717_CR4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4161\/mabs.25423","volume":"5","author":"D Ayoub","year":"2013","unstructured":"Ayoub D, Jabs W, Resemann A, Evers W, Evans C, Main L, Baessmann C, Wagner-Rousset E, Suckau D, Beck A (2013) Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. MAbs 5:699\u2013710","journal-title":"MAbs"},{"key":"7717_CR5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1572-0241.2003.07343.x","volume":"98","author":"R Baldassano","year":"2003","unstructured":"Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, Winter HS (2003) Infliximab (REMICADE) therapy in the treatment of pediatric Crohn\u2019s disease. Am J Gastroenterol 98:833\u2013838","journal-title":"Am J Gastroenterol"},{"key":"7717_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567\u2013578","journal-title":"N Engl J Med"},{"key":"7717_CR7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4161\/mabs.2.3.11780","volume":"2","author":"RJ Brezski","year":"2010","unstructured":"Brezski RJ, Jordan RE (2010) Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? MAbs 2:212\u2013220","journal-title":"MAbs"},{"key":"7717_CR8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00253-004-1559-9","volume":"64","author":"JH Choi","year":"2004","unstructured":"Choi JH, Lee SY (2004) Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 64:625\u2013635","journal-title":"Appl Microbiol Biotechnol"},{"key":"7717_CR9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","volume":"358","author":"CH Chung","year":"2008","unstructured":"Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 358:1109\u20131117","journal-title":"N Engl J Med"},{"key":"7717_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00007890-198112000-00018","volume":"32","author":"AB Cosimi","year":"1981","unstructured":"Cosimi AB, Burton RC, Colvin RB, Goldstein G, Delmonico FL, LaQuaglia MP, Tolkoff-Rubin N, Rubin RH, Herrin JT, Russell PS (1981a) Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 32:535\u2013539","journal-title":"Transplantation"},{"key":"7717_CR11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJM198108063050603","volume":"305","author":"AB Cosimi","year":"1981","unstructured":"Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen WP, Delmonico FL, Russell PS (1981b) Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med 305:308\u2013314","journal-title":"N Engl J Med"},{"key":"7717_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","volume":"351","author":"D Cunningham","year":"2004","unstructured":"Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337\u2013345","journal-title":"N Engl J Med"},{"key":"7717_CR13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, WG S, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486\u2013501","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"7717_CR14","first-page":"4322","volume":"53","author":"Z Fan","year":"1993","unstructured":"Fan Z, Masui H, Altas I, Mendelsohn J (1993) Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 53:4322\u20134328","journal-title":"Cancer Res"},{"key":"7717_CR15","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.1016\/S0021-9258(17)42857-2","volume":"259","author":"GN Gill","year":"1984","unstructured":"Gill GN, Kawamoto T, Cochet C, Le A, Sato JD, Masui H, McLeod C, Mendelsohn J (1984) Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 259:7755\u20137760","journal-title":"J Biol Chem"},{"key":"7717_CR16","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","volume":"23","author":"P Holliger","year":"2005","unstructured":"Holliger P, Hudson PJ (2005) Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23:1126\u20131136","journal-title":"Nat Biotechnol"},{"key":"7717_CR17","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1073\/pnas.80.5.1337","volume":"80","author":"T Kawamoto","year":"1983","unstructured":"Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J (1983) Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A 80:1337\u20131341","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7717_CR18","doi-asserted-by":"crossref","first-page":"e113442","DOI":"10.1371\/journal.pone.0113442","volume":"9","author":"YP Kim","year":"2014","unstructured":"Kim YP, Park D, Kim JJ, Chi WJ, Lee SH, Lee SY, Kim S, Chung JM, Jeon J, Lee BD, Shin JH, Lee YI, Cho H, Lee JM, Kang HC (2014) Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor. PLoS One 9:e113442","journal-title":"PLoS One"},{"key":"7717_CR19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G Kohler","year":"1975","unstructured":"Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495\u2013497","journal-title":"Nature"},{"key":"7717_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccr.2005.03.003","volume":"7","author":"S Li","year":"2005","unstructured":"Li S, Schmitz KR, Jeffrey PD, Wiltzius JJ, Kussie P, Ferguson KM (2005) Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7:301\u2013311","journal-title":"Cancer Cell"},{"key":"7717_CR21","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16:2825\u20132833","journal-title":"J Clin Oncol"},{"key":"7717_CR22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","volume":"356","author":"PJ Mease","year":"2000","unstructured":"Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356:385\u2013390","journal-title":"Lancet"},{"key":"7717_CR23","first-page":"747","volume":"6","author":"J Mendelsohn","year":"2000","unstructured":"Mendelsohn J (2000) Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture. Clin Cancer Res 6:747\u2013753","journal-title":"Clin Cancer Res"},{"key":"7717_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","volume":"7","author":"PD Miller","year":"2009","unstructured":"Miller PD (2009) Denosumab: anti-RANKL antibody. Curr Osteoporos Rep 7:18\u201322","journal-title":"Curr Osteoporos Rep"},{"key":"7717_CR25","volume-title":"HKL2000 (Denzo-SMN) software package. Processing of X-ray diffraction data collected in oscillation mode. Methods in enzymology, macromolecular crystallography","author":"W Minor","year":"1997","unstructured":"Minor W, Otwinowski Z (1997) HKL2000 (Denzo-SMN) software package. Processing of X-ray diffraction data collected in oscillation mode. Methods in enzymology, macromolecular crystallography. Academic Press, New York"},{"key":"7717_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0021-9258(19)86257-9","volume":"255","author":"NR Movva","year":"1980","unstructured":"Movva NR, Nakamura K, Inouye M (1980) Amino acid sequence of the signal peptide of ompA protein, a major outer membrane protein of Escherichia coli. J Biol Chem 255:27\u201329","journal-title":"J Biol Chem"},{"key":"7717_CR27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera--a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612","journal-title":"J Comput Chem"},{"key":"7717_CR28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nbt0905-1073","volume":"23","author":"JM Reichert","year":"2005","unstructured":"Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC (2005) Monoclonal antibody successes in the clinic. Nat Biotechnol 23:1073\u20131078","journal-title":"Nat Biotechnol"},{"key":"7717_CR29","first-page":"511","volume":"1","author":"JD Sato","year":"1983","unstructured":"Sato JD, Kawamoto T, Le AD, Mendelsohn J, Polikoff J, Sato GH (1983) Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med 1:511\u2013529","journal-title":"Mol Biol Med"},{"key":"7717_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pep.2012.11.002","volume":"87","author":"JT Sockolosky","year":"2013","unstructured":"Sockolosky JT, Szoka FC (2013) Periplasmic production via the pET expression system of soluble, bioactive human growth hormone. Protein Expr Purif 87:129\u2013135","journal-title":"Protein Expr Purif"},{"key":"7717_CR31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","volume":"360","author":"E Cutsem Van","year":"2009","unstructured":"Van Cutsem E, Kohne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, D\u2019Haens G, Pinter T, Lim R, Bodoky G, Roh JK, Folprecht G, Ruff P, Stroh C, Tejpar S, Schlichting M, Nippgen J, Rougier P (2009) Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360:1408\u20131417","journal-title":"N Engl J Med"},{"key":"7717_CR32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/prep.2001.1444","volume":"22","author":"H Wlad","year":"2001","unstructured":"Wlad H, Ballagi A, Bouakaz L, Gu Z, Janson JC (2001) Rapid two-step purification of a recombinant mouse fab fragment expressed in Escherichia coli. Protein Expr Purif 22:325\u2013329","journal-title":"Protein Expr Purif"},{"key":"7717_CR33","first-page":"3402","volume":"52","author":"T Yokota","year":"1992","unstructured":"Yokota T, Milenic DE, Whitlow M, Schlom J (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 52:3402\u20133408","journal-title":"Cancer Res"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7717-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-016-7717-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7717-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T02:06:05Z","timestamp":1656900365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-016-7717-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":33,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["7717"],"URL":"https:\/\/doi.org\/10.1007\/s00253-016-7717-z","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,28]]}}}